glp-1 drugs and crohn's disease Use in Disease: Safety & IBD Considerations – PlexusDx GLP-1s and Crohn's Disease: Safety,

Emerging evidence suggests that GSH, along with its enzymatic counterparts including glutathione peroxidases, glutathione reductase, and glutathione S-transferases, activates plant defense responses by multiple ways such as by (1) triggering the activation of defense-related genes and the production of defense compounds including phytoalexins, (2) preventing excessive cell damage and facilitating controlled cell death during hypersensitive response, (3) influencing salicylic acid and jasmonic acid pathways to shape the systemic acquired resistance and induced systemic resistance, respectively, and (4), conjugating with and detoxifying pathogen-secreted toxins and other harmful compounds produced during pathogen attack, thereby protecting plant cells from potential damage

Digestive enzymes and betaine HCL supplementation may support overall digestive function during BPC-157 treatment

, ,

Genetic factors: Variants in genes 5 that regulate DAO or HNMT enzymes

While annoying, this side effect is usually mild and temporary